203 related articles for article (PubMed ID: 37121858)
21. Arterial and vena caval resections combined with pancreaticoduodenectomy in highly selected patients with periampullary malignancies.
Nakano H; Bachellier P; Weber JC; Oussoultzoglou E; Dieng M; Shimura H; Boudjema K; Wolf P; Jaeck D
Hepatogastroenterology; 2002; 49(43):258-62. PubMed ID: 11941970
[TBL] [Abstract][Full Text] [Related]
22. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
23. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
[TBL] [Abstract][Full Text] [Related]
24. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
[TBL] [Abstract][Full Text] [Related]
25. Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
Tseng JF; Raut CP; Lee JE; Pisters PW; Vauthey JN; Abdalla EK; Gomez HF; Sun CC; Crane CH; Wolff RA; Evans DB
J Gastrointest Surg; 2004 Dec; 8(8):935-49; discussion 949-50. PubMed ID: 15585381
[TBL] [Abstract][Full Text] [Related]
26. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.
Bhatti I; Peacock O; Awan AK; Semeraro D; Larvin M; Hall RI
World J Surg; 2010 Apr; 34(4):768-75. PubMed ID: 20052471
[TBL] [Abstract][Full Text] [Related]
27. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.
Jamieson NB; Foulis AK; Oien KA; Going JJ; Glen P; Dickson EJ; Imrie CW; McKay CJ; Carter R
Ann Surg; 2010 Jun; 251(6):1003-10. PubMed ID: 20485150
[TBL] [Abstract][Full Text] [Related]
28. Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma?
Jung JP; Zenati MS; Hamad A; Hogg ME; Simmons RL; Zureikat AH; Zeh HJ; Boone BA
HPB (Oxford); 2019 Jun; 21(6):679-686. PubMed ID: 30501987
[TBL] [Abstract][Full Text] [Related]
29. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
30. Carcinoma of the pancreas with portal vein involvement--our experience with a modified technique of resection.
Jain S; Sacchi M; Vrachnos P; Lygidakis NJ
Hepatogastroenterology; 2005; 52(65):1596-600. PubMed ID: 16201124
[TBL] [Abstract][Full Text] [Related]
31. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
Marsoner K; Langeder R; Csengeri D; Sodeck G; Mischinger HJ; Kornprat P
Wien Klin Wochenschr; 2016 Aug; 128(15-16):566-72. PubMed ID: 27363995
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic pancreaticoduodenectomy with portal or superior mesenteric vein resection and reconstruction for pancreatic cancer: A single-center experience.
Ma MJ; Cheng H; Chen YS; Yu XJ; Liu C
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):147-153. PubMed ID: 36690522
[TBL] [Abstract][Full Text] [Related]
33. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
[TBL] [Abstract][Full Text] [Related]
34. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
35. Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center.
van Roessel S; Kasumova GG; Tabatabaie O; Ng SC; van Rijssen LB; Verheij J; Najarian RM; van Gulik TM; Besselink MG; Busch OR; Tseng JF
Ann Surg Oncol; 2018 Jun; 25(6):1760-1767. PubMed ID: 29651577
[TBL] [Abstract][Full Text] [Related]
36. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?
Turrini O; Ewald J; Barbier L; Mokart D; Blache JL; Delpero JR
Ann Surg; 2013 Apr; 257(4):726-30. PubMed ID: 22968078
[TBL] [Abstract][Full Text] [Related]
37. Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy.
Liszka Ł; Pajak J; Zielińska-Pajak E; Gołka D; Mrowiec S; Lampe P
Pathology; 2010 Feb; 42(2):138-46. PubMed ID: 20085515
[TBL] [Abstract][Full Text] [Related]
38. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
39. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
